GlassScriptPhysician profile
Eugene C Brown, JR.
NPI 1780755165
$2,631.31
in general payments reported to CMS, 2019-2025
10 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,379 · 2020: $153 · 2021: $204 · 2022: $391 · 2023: $220 · 2024: $161 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370 · Consulting Fee: $75.00 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.10 |
| Consulting Fee | $75.00 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $1,727.06 | 2019-2023 | Spark, Damon |
| Align Technology, INC. | $394.77 | 2020-2025 | Invisalign |
| World Class Technology Corporation | $186.98 | 2019-2021 | |
| Envista Holdings Corporation | $111.91 | 2024-2025 | Spark, Damon Clear |
| Nobel Biocare USA | $104.89 | 2023 | Nobelactive |
| Solventum Corporation | $35.34 | 2025 | Apc Flash-Free Victory Series Low Profile |
| Dentsply Sirona Orthodontics INC | $26.89 | 2019-2020 | |
| 3m Company | $17.55 | 2021 | |
| American Orthodontics Corporation | $13.08 | 2025 | Empower-Metal, Radiance, Empower-Ceramic |
| Dentsply Sirona INC | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.